Yantai Dongcheng Pharmaceutical Group Co., Ltd., commonly referred to as Dongcheng Pharmaceutical, is a leading player in the pharmaceutical industry, headquartered in Yantai, China. Established in 1995, the company has made significant strides in the development and production of a diverse range of pharmaceutical products, including active pharmaceutical ingredients (APIs) and finished dosage forms. With a strong presence in both domestic and international markets, Dongcheng Pharmaceutical is renowned for its commitment to quality and innovation. The company’s core offerings, which include anti-infectives and cardiovascular medications, are distinguished by their adherence to stringent regulatory standards and advanced manufacturing processes. Recognised for its robust market position, Dongcheng Pharmaceutical continues to achieve notable milestones, solidifying its reputation as a trusted name in healthcare solutions.
How does Yantai Dongcheng Pharmaceutical Group Co.,Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Yantai Dongcheng Pharmaceutical Group Co.,Ltd.'s score of 23 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Yantai Dongcheng Pharmaceutical Group Co., Ltd., headquartered in China, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Furthermore, the company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to reducing carbon emissions at this time. As there are no emissions data or reduction initiatives available, it is unclear how Yantai Dongcheng Pharmaceutical Group aligns with industry standards for climate action. The absence of specific targets or commitments may reflect a broader context within the pharmaceutical industry, where companies are increasingly being urged to adopt more robust climate strategies and transparency in emissions reporting. Overall, without available data or commitments, Yantai Dongcheng Pharmaceutical Group's current stance on carbon emissions and climate action remains undefined.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.